Hims & Hers Health, Inc. (HIMS) vs JOHNSON & JOHNSON(JNJ)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | HIMS | JNJ |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $2.35B | $94.19B |
| Revenue growth (YoY) | ▲ 59.0% | ▲ 6.0% |
| Net income | $128.37M | $26.80B |
| Gross margin | 73.8% | 67.9% |
| Diluted EPS | $0.51 | $11.03 |
| Insider net (6 mo) | −1.8M sh · 23 sells · 1 buys | −40.8K sh · 6 sells · 0 buys |
| Institutional owners | 40 | 47 |
| Institutional value held | $6.17B | $294.77B |
| Next earnings (est.) | Around Nov 2, 2026 | Around Oct 13, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc., launched in 2017 and headquartered operations built around a consumer-first digital health platform, connects consumers with licensed healthcare providers for telehealth consultations and prescription and non-prescription products add
About JOHNSON & JOHNSON (JNJ)
Johnson & Johnson, incorporated in New Jersey in 1887, is a global healthcare holding company with approximately 138,200 full-time-equivalent employees engaged in the research, development, manufacture, and sale of a broad range of healthcare products.
Source: SEC EDGAR.